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Exposure during the organogenesis stage of the mouse embryo
to the model teratogen, hydroxyurea (HU), induces curly tail and
limb malformations. Oxidative stress contributes to the develop-
mental toxicity of HU. Reactive oxygen species (ROS) interact
with polyunsaturated bilipid membranes to form a,b-unsaturated
reactive aldehydes; 4-hydroxy-2-nonenal (4-HNE), one of the
most cytotoxic of these aldehydes, covalently adducts with
proteins, lipids, and nucleic acids. The goal of the current study
is to determine if HU exposure of CD1 mice on gestation day 9
generates region-speciﬁc 4-HNE-protein adducts in the embryo
and to identify the proteins targeted. The formation of 4-HNE-
protein adducts was elevated in the caudal region of control embryos;
HU exposure further increased 4-HNE-protein adduct formation in
this area. Interestingly, three of the 4-HNE–modiﬁed proteins,
glyceraldehyde-3-phosphate dehydrogenase (GAPDH), glutamate
oxaloacetate transaminase 2, and aldolase 1, A isoform, are involved
in energy metabolism. The formation of 4-HNE-GAPDH protein
adducts reduced GAPDH enzymatic activity by 20% and attenuated
lactate production by 40%. Furthermore, HU exposure induced the
nuclear translocation of GAPDH in the caudal region of exposed
embryos; this nuclear translocation may be associated with the
reactivation of oxidized proteinsi n v o l v e di nD N Ar e p a i r ,s u c ha s
apurinic/apyrimidinic endonuclease-1, and the stimulation of E1A-
associated P300 protein/creb-binding protein (p300/CBP) activity,
initiating cell death in a p53-dependent pathway. We propose that
GAPDH is a redox-sensitive target in the embryo and may play
a role in a stress response during development.
Key Words: 4-hydroxy-2-nonenal;proteinadducts;glyceraldehyde-
3-phosphate dehydrogenase; oxidative stress; nuclear translocation;
glycolysis.
Reactive oxygen species (ROS) play a signiﬁcant role in
embryonic development. ROS modulate signaling pathways
that promote differentiation, proliferation, and apoptosis
(Dennery, 2007). Excess ROS lead to oxidative stress and
the perturbation of redox-sensitive signaling pathways, some of
which are associated with dysmorphogenesis (Ozolins and
Hales, 1997). During midorganogenesis, a period when the
embryo is undergoing rapid cellular growth and differentiation
leading to major structural changes, ROS may play an
important role in mediating teratogenic insult. The mechanisms
by which oxidative stress leads to embryotoxicity and
teratogenesis are still not fully understood.
ROS contribute to embryonic maldevelopment by modifying
redox-sensitive signaling pathways critical to development.
During organogenesis, oxidative stress posttranslationally mod-
iﬁes redox-regulated transcription factors with subsequent changes
in gene expression in the embryo (Dennery, 2007). A caudal iso-
form of Wnt, Wnt8c, important for body patterning and organo-
genesis (Geetha-Loganathan, 2008), is perturbed by H2O2,
inducing rapid stabilization of b-catenin and increasing the
expression of Wnt target genes (Korswagen, 2006). Activator
protein-1 (AP-1) is a redox-sensitive early response transcription
factor composed of Jun and Fos families of nuclear proteins
whose gene products are associated with antioxidant defense, cell
cycle control, and apoptosis. Hydroxyurea (HU), a free-radical
producing teratogen, induces oxidative stress during organogen-
esis, enhancing the formation of c-Fos heterodimers and leading
to increased AP-1 DNA-binding activity (Yan and Hales, 2005).
Transgenic overexpression of superoxide dismutase (hSOD1)i n
dams treated with HU lowers the incidence of malformations
(Larouche and Hales, 2009). It is clear that oxidative stress plays
a critical role in HU-induced developmental defects.
ROS may also cause embryotoxicity by inducing lipid
peroxidation. Free-radical chain oxidation reactions with poly-
unsaturated fatty acids within cellular membranes produce
electrophilic aldehydes (Sayre et al.,2 0 0 6 ). 4-Hydroxy-2-
nonenal (4-HNE) is one of the most widely recognized and
most studied cytotoxic products of lipid peroxidation (Uchida,
2003). 4-HNE is diffusible; it may act locally or be distributed to
other tissues through the circulation (Sayre et al.,2 0 0 6 ). Michael
addition reactions with the side chain of cysteine are highly
susceptible to covalent modiﬁcations by 4-HNE (Grimsrud
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of the stress response. A number of the protein targets of 4-
HNE affect energy production. Glycolytic enzymes, namely,
glyceraldehyde-3-phosphate dehydrogenase (GAPDH), phos-
phofructokinase, aldolase, and lactate dehydrogenase, are redox
sensitive and form covalent modiﬁcations with 4-HNE (Novotny
et al.,1 9 9 4 ). Previous studies from our laboratory have revealed
the formation of region-speciﬁc 4-HNE adducts in teratogen-
exposed organogenesis stage mouse embryos.
Glycolytic enzymes are of particular interest as sensitive targets
of ROS within the developing embryo because they are critically
required for ATP production (Dumollard et al.,2 0 0 9 ; Grant,
2008; Neubert, 1970). GAPDH is inactivated during periods of
oxidative stress and is modiﬁed by 4-HNE in several experimen-
tal models (Botzen and Grune, 2007; Schutt et al., 2003; Uchida
and Stadtman, 1993). GAPDH, once thought to be involved only
in cellular maintenance, is now recognized as an important
multifunctional entity. There is compelling evidence that GAPDH
is a developmentally critical enzyme that protects the embryo
from endogenous and xenobiotic-initiated oxidative stress and
DNA damage that results in a broad range of embryopathies.
Posttranslational modiﬁcations of GAPDH during oxidative stress
are thought to be responsible for its multiple cellular functions,
including p53-dependent cell death (Hwang et al., 2009; Sen
et al., 2008). HU, a model teratogen, is used as an anticancer
agent and for the treatment of sickle cell disease. HU is a potent
inhibitor of class I ribonucleotide reductase, quenching the tyrosyl
free radical within its catalytic center, resulting in inhibition of
DNA replication and the induction of oxidative stress. HU
exposure on gestation day 9 (GD 9) causes a dose-dependent
increase in caudal defects, mainly hindlimb and lumbosacral
vertebral column defects. Pretreatment with antioxidants ameli-
orates HU-induced malformations and impedes the onset of
apoptosis (DeSesso, 1981; DeSesso et al., 1994). We have shown
previously that HU causes a dose-dependent increase in 4-HNE-
protein adduct immunoreactivity in the caudal tissues in
organogenesis stage embryos; HU-induced malformations and
4-HNE adducts were increased by treatment with L-buthionine-
S,R-sulfoximine, an irreversible inhibitor of c-glutamylcysteine
synthetase that results in the depletion of glutathione and an
increase in oxidative stress (Yan and Hales, 2006). The role of
4-HNE-protein adducts in oxidative stress–induced teratogen-
esis and the region-speciﬁc effects and pathways abrogated by
4-HNE that have a potential impact on caudal malformations
have yet to be deﬁned. The goal of this study is to determine if
HU exposure generates 4-HNE-protein adducts in malforma-
tion-sensitive regions of the embryo, identify the proteins
targeted, assess the effects on protein function, and localize 4-
HNE-adducted targets.
MATERIALS AND METHODS
Timed-pregnant CD1 mice were purchased from Charles River Canada Ltd
(St Constant, Quebec, Canada) and housed in the McIntyre Animal Resource
Centre (McGill University, Montreal, Quebec, Canada). Animal protocols
were conducted in accordance with the guidelines outlined in the Guide to the
Care and Use of Experimental Animals. CD1 mice mated between 8:00 and
10:00 A.M. (GD 0) were treated with saline (control) or HU (Aldrich Chemical
Co., Madison, WI) at 400 or 600 mg/kg by ip injection at 9:00 A.M.o nG D9 .
Female mice were euthanized by CO2 and cervical dislocation on GD 9 at 3 h
after treatment; each treatment group consisted of 7–12 litters. On GD 9, the
uteri were removed and embryos were explanted to Hanks’ balanced salt
solution (Invitrogen Canada, Inc., Ontario, Canada). Embryos were cut into
head, body, and tail sections (Fig. 1). Protein extracts were obtained
immediately for assessment of 4-HNE-protein adducts by Western blotting or
the analysis of GAPDH enzymatic activity. For two-dimensional (2D) gel
electrophoresis, the tail parts from four litters of embryos exposed to vehicle or
HU600 were pooled and subjected to protein extraction immediately. Embryos
were left whole for lactate assays and immunoﬂuorescence.
1D and 2D gel electrophoresis and Western blot analysis of 4-HNE-
protein adducts. For 4-HNE-protein adduct determination using 1D gel
electrophoresis, 7.5 lg of protein from each sample was separated by 10%
SDS-polyacrylamide gel electrophoresis (PAGE) (15 wells) and then transferred
onto equilibrated polyvinylidene diﬂuoride membranes (PVDF) (Amersham
Biosciences, Buckinghamshire, U.K.) by electroblotting. Protein concentrations
were determined using the Bio-Rad Bradford protein assay (Bio-Rad Laborato-
ries, Ontario, Canada). To analyze GAPDH using Western blotting of proteins
from fractionated (head, body, and tail) embryos, 20 lg of protein from each
sample was separated by 8% SDS-PAGE and then transferred onto PVDF
membranes (Invitrogen Corporation). Membranes were blocked using 10% nonfat
milk and then probed with primary antibodies against 4-HNE-protein adducts
(1:500; OXIS International, Inc., Foster City, CA), GAPDH (1:1000; Abcam,
Inc., Cambridge, MA), and b-actin (1:5000; Santa Cruz Biotechnology, Inc.,
Santa Cruz, CA) overnight at 4C. Membranes were incubated with horseradish
peroxidase–conjugated secondary antibodies (1:10,000; GE Healthcare, Buck-
inghamshire, U.K.) for 2 h at room temperature, and proteins were detected by
enhanced chemiluminescence (GE Healthcare). Protein bands were quantiﬁed by
densitometric analysis using a ChemiImager 400 Imaging system (Alpha
Innotech, San Leandro, CA); the peak area represents the intensity of the signal.
For 2D gel electrophoresis, protein determination, separation, and mass
spectrometry were conducted by the Genome Quebec Innovation Centre
(Montreal, Quebec, Canada). Protein concentration was determined with use of
2D Quant Kit (Amersham, Baie D’Urfe, Quebec, Canada). Fifty micrograms of
protein in 155 ll of Destreak rehydration buffer supplemented with 1% IPG
Buffer (3–10 NL, Amersham) were placed in each of four chambers of ZOOM
IPGRunner Cassette (Invitrogen). ZOOM Dry Strips (7 cm, pH range 3–10 NL,
Invitrogen) were placed in the chambers that were then sealed and left for
rehydration for 16 h. The cassette was inserted in ZOOM IPGRunner (Invitrogen
Canada, Inc.) and voltage gradient (200–2000 V) was applied as recommended by
the manufacturer. A total of 2000 Vh was applied. After isoelectric focusing was
completed, strips were equilibrated with SDS using NuPAGE LDS Sample Buffer
(13, Invitrogen Canada, Inc.), reduced with 2% dithiothreitol (DTT, Amersham),
and alkylated with iodacetamide (IAA, Sigma). Both steps (DTT and IAA) were
done at room temperature for 15 min. Electrophoresis in the second dimension
(SDS-PAGE) was done on gradient 4–12% BisTris precast minigels (Invitrogen)
immobilized with 1% agarose in XCell SureLock (Invitrogen). The upper and
lower chambers were ﬁlled with MOPS Running Buffer (Invitrogen); molecular
weight standards (Broad Range Protein Molecular Weight Markers, Amersham,
0.9 lg/gel) were placed in the marker wells, and 200 V were applied for 50 min.
After completion of the run, one of every pair of gels was ﬁxed overnight in 50%
methanol/10% acetic acid ﬁxation solution and stained with silver nitrate by
modiﬁed Shevchenko’s protocol (Yan et al., 2000). Gel images were acquired on
an ImageScanner (Amersham) in TIF format.
Immediately after SDS-PAGE, the second gel was covered with
a nitrocellulose membrane, placed between two sheets of Whatman paper
and two sponges, and inserted into an XCell II Blot Module (Invitrogen). The
module was then placed in XCell SureLock. Transfer Buffer (Invitrogen)
supplemented with 10% methanol was added in the module, and protein
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controlled by staining with Ponceau S. The membranes were blocked with 5%
skim milk for 1 h at room temperature after washing off the Ponceau S stain and
then probed with primary antibodies against 4-HNE–modiﬁed proteins (1:500,
OXIS International, Inc.) overnight at 4C. After incubation with horseradish
peroxidase–conjugated secondary antibodies (1:10,000) for 2 h at room
temperature, proteins were detected with the same method as 1D gels.
Mass spectrometry. Protein spots on the silver-stained 2D gels that
correspond to those detected by immunoblotting of 4-HNE–modiﬁed proteins
were excised from the gel and subjected to trypsin digestion. Sample injection
and high-performance liquid chromatography (HPLC) separation were done
using an Agilent 1100 series system (Agilent Technologies, Ontario, Canada).
Twenty microliters of digest solution were loaded onto a Zorbax 300SB-C18
5 3 0.3 mm trapping column and washed for 5 min at 15 ll/min with 3%
acetonitrile (ACN):0.1% formic acid (FA). Nano-HPLC peptide separation was
done using a New Objective (Woburn, MA) Biobasic C18 10 3 0.075 mm
picofrit analytical column. The gradient was 10% ACN:0.1% FA to 95%
ACN:0.1% FA in 15 min at 200 nl/min.
Mass spectrometry was done with a QTRAP 4000 from Sciex-Applied
Biosystems (Concord, Ontario, Canada). Information-dependent mass spectrometry/
mass spectrometry (MS/MS) analysis was done on the three most intense ions
selected from each full scan MS with dynamic exclusion for 90 s. The survey
scan used was an enhanced MS scan from 3500 to 1600 m/z at 4000 amu/s
using dynamic ﬁll time. MS/MS data were acquired for three scans from 70 to
1700 m/z using a ﬁxed 25 ms trap ﬁll time and with Q0 trapping activated.
Peaklists were generated with Mascot Distiller 1.1 from Matrixscience (Boston,
MA). Searches of sequences from NCBInr database using a rodent taxonomy
ﬁlter (157,986 sequences) were done with Mascot 1.9 using trypsin as digestion
enzyme, carboxyamidomethylation of cysteines as ﬁxed modiﬁcation, and
methionine oxidation as variable modiﬁcation and 1.5 Da precursor and 0.8
fragment search tolerances.
2D Western blot analysis of GAPDH. Membranes obtained from 2D
Western blot of 4-HNE–modiﬁed proteins were stripped once with stripping buffer
(2% SDS; 62.5mM Tris, pH 6.7; 100mM b-mercaptoethanol). After washing three
times with tris-buffered saline tween-20 (0.1% Tween-20) for 10 min each,
membranes were blocked with 5% skim milk for 1 h at room temperature, probed
with a primary antibody against GAPDH (1:2000, rabbit polyclonal immuno-
globulin G [IgG], Abcam, Inc.) at 4C overnight, and incubated with horseradish
peroxidase–conjugated secondary antibody (1:10,000, GE Healthcare) for 2 h at
room temperature. Proteins were detected and quantiﬁed with the same protocol as
1D gels.
GAPDH enzyme assay. GD 9 embryos were separated into head, body, and
tail and pooled from three litters for each treatment group, homogenized in lysis
buffer containing protease cocktail inhibitor, and used for the two-step enzymatic
reaction in the production of reduced nicotinamide adenine dinucleotide
(NADH). The enzyme assay mixture contained 100mM triethanolamine buffer,
pH 7.6, 100mM 3-phosphoglyceric acid, 200mM L-cysteine HCL, 100mM
magnesium sulfate, 7.0mM b-nicotinamide adenine dinucleotide, 34mM
adenosine triphosphate, and 200 units/ml 3-phosphoglyceric phosphokinase (3-
PGK); all reagents were dissolved in deionized water. 3-PGK was added last to
start the reaction; all reagents were mixed by inversion and equilibrated to 25C.
Spectrophotometric absorbance was measured for NADH production at 340 nm
for approximately 5 min, and the DA340/min was measured using the maximum
linear rate for both test and blank.
Lactate assay. GD 9 whole embryos were pooled from three litters from each
treatment group, homogenized in lysis buffer, ﬂash frozen, and stored at  80C.
Reaction ingredients, including 700 units/l of lactate oxidase, 508 units/l of
peroxidase, 2.0 mmol/l of dichlorobenzenesulfonic acid (DCBSA), and 1.16 mmol/l
of 4-aminoantipyrine (4-AAP), were added to the homogenized sample (Policy
and Procedure Central Laboratory, Biochemistry, McGill University Health
Centre). In the reaction, lactate oxidase converts lactate into pyruvate with the
simultaneous generation of hydrogen peroxide (H2O2). The H2O2 reacts with
DCBSA and 4-AAP to form a chromophore, catalyzed by peroxidase. The lactic
acid concentration is determined by measuring the change in absorbance at 520 nm.
Immunoﬂuorescence. Three hours after the treatment of dams with HU or
vehicle on GD 9, embryos were explanted and immersed in 4% paraformaldehyde
FIG. 1. Illustration of the separation of the mouse embryo. Head part (h), from the cranial end (top) of the embryo to the caudal end of the ﬁrst branchial arch;
body part (b), the region between the head and the tail part; tail part (t), from the cranial border of the third somites (counted from the caudal end) to the caudal end
of the embryo. (A) Western blot analysis of 4-HNE-protein adducts in the three parts of embryos exposed to vehicle (saline) or HU (HU400, 400 mg/kg or HU600,
600 mg/kg). All 4-HNE-protein adducts were quantiﬁed by scan densitometric analysis, as indicated in (B). Each bar (mean ± SEM) represents three litters.
‘‘Dagger’’ denotes a signiﬁcant difference between different parts of the embryo within the same treatment group (†p < 0.05).
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a n ds e r i a l l ys e c t i o n e d( 5 - lm sections) along the sagittal plane. Tissues were
deparafﬁnized and rehydrated with PBS for 5 min and then incubated for 30 min
in blocking serum (0.1% bovine serum albumin, 0.1% Triton X-100, and PBS).
Blocking serum was gently tipped off the slides, and then the sections were
incubated with GAPDH primary antibody (1:100; Abcam, Inc., diluted in
blocking serum) overnight at 4C in a humidiﬁed chamber. Sections were rinsed
three times for 5 min in PBS and then incubated with secondary anti-rabbit IgG
(1:200; Vector Laboratories, Inc.) diluted in blocking serum for 1 h at room
temperature. After washing three times for 5 min in PBS, tissues were counter-
stained with 4#,6-diamidino-2-phenylindole (DAPI) for 5 min and then washed
again with PBS for 5 min. Slides were mounted with Vectashield for ﬂuorescence
(Vector Laboratories, Inc.). As a negative control, only the secondary antibody
was added.
Confocal microscopy and quantitative analysis. A Zeiss LSM 510
Axiovert 100 M confocal microscope with a Plan-Apochromat 363/1.4 oil
digital image correlation objective was used to visualize the ﬂuorescent GAPDH-
stained sagittal sections of embryos treated with vehicle and HU. Optimal
settings for laser scanning ﬂuorescence imaging were determined experimentally
for both GAPDH antibody and DAPI. All embryos were scanned at a 1.28-ls
pixel time speed with an optical slice of approximately 0.6 lm, zoom factor equal
to one, and a pinhole setting of 82 lmf o rG A P D Ha n d1 0 0 0lmf o rD A P I .
Z-stack images of six independent vehicle-treated and seven independent
HU600-treated embryos were acquired, and quantitative analysis was done with
IMARIS Software (Bitplane AG, Zurich, Switzerland). 3D iso-surfaces of
vehicle- and HU600-treated embryos were generated. Only lumbosacral somites
were analyzed in this study. 3D surface–rendered GAPDH was isolated from the
3D surface–rendered DAPI. The software enabled GAPDH to be subtracted from
the cytoplasm, isolating the colocalized DAPI and GAPDH surfaces to be
analyzed by intensity mean.
Statistical analyses. Statistical analyses were done by a one-way or a two-
way ANOVA on ranks, as appropriate, using the SigmaStat computer program,
followed by a post hoc Holm-Sidak or Dunn’s analysis of the 1D and 2D gel
electrophoresis. A one-way ANOVA, followed by the Bonferroni correction for
multiple testing, was done for the GAPDH enzymatic analysis and lactate
measurements. A Student’s t-test was performed using GraphPrism to test for
intensity mean differences. The a priori level of signiﬁcance was p < 0.05.
RESULTS
4-HNE Is Differentially Localized in the Embryo
Proteins extracted from head, body, and tail of control and
HU-exposed embryos were analyzed by Western blot analysis
to determine the relative distribution of 4-HNE-protein adducts.
A major 4-HNE immunoreactive band was observed in the 65
kDa molecular weight range (Fig. 1A). Interestingly, a higher
content of the 65 kDa 4-HNE-protein adducts was found in the tail
than in the head or body region of both control embryos and those
treated with HU (400 or 600 mg/kg) (Fig. 1B). Multiple low-
intensity bands of 4-HNE-protein adducts were detected below 50
kDa (Fig. 2A), but none were greater in content in any of the three
body regions of the embryo in any treatment group (Fig. 1B).
The Identiﬁcation of 4-HNE–Conjugated Proteins
To identify the 4-HNE-protein adducts enriched in the
embryonic tail region, after exposure to vehicle or 600 mg/kg
HU, embryo tails were excised and subjected to 2D gel
electrophoresis (Fig. 2). 4-HNE–modiﬁed protein immunore-
activity revealed eight protein spots in both control and HU-
treated embryos. According to the molecular weight range,
spots 7 and 8 may be the 4-HNE-protein adducts concentrated
in the tail part, whereas spots 1–6 may be more evenly
distributed throughout the three embryo regions.
Using MS, identiﬁcations were assigned to seven spots
(2–8), as summarized in Table 1. The tail-localized 4-HNE–
modiﬁed proteins were identiﬁed as albumin (spot 7),
chaperonin subunit theta, and possibly heat shock 60 kDa
protein 1 (HSPD1, spot 8). 2D Western blots (n ¼ 2) did not
detect a consistent change in the intensity of these three protein
adducts when control embryos were compared with HU-
exposed embryos. Interestingly, among the lower molecular
weight protein adducts (perhaps not tail speciﬁc), three of the
identiﬁed proteins are involved in energy metabolism. These
include glutamate oxaloacetate transaminase 2 (GOT2, spot 2);
aldolase 1, A isoform (ALDOA1, spot 3); and GAPDH (spot
5). HU exposure resulted in increases in 4-HNE–conjugated
GOT2 (1.6-fold), ALDOA1 (1.6-fold), and GAPDH (1.8-fold)
compared with controls. The two remaining 4-HNE–modiﬁed
proteins that were identiﬁed are inducible small cytokine
subfamily E member 1 (SCYE1, spot 4) and heterogeneous
nuclear ribonucleotide protein A1 isoform a (HNRNP A1A,
spot 6). HU exposure increased the amounts of both SCYE1
(1.8-fold) and HNRNP A1A (2.1-fold) compared with control.
4-HNE Modiﬁcations Alter GAPDH Protein
Because glycolysis is a critical energy pathway during
organogenesis, we further investigated the importance of
GAPDH as a 4-HNE-protein target in the malformation-
sensitive tail region of HU-exposed embryos using 2D Western
blot analysis (Fig. 3). Western blots of the tail parts of the
embryo exposed to saline or HU600 resulted in an immuno-
reactive spot that matched that of the spot corresponding to the
silver-stained gel identiﬁed by MS (Figs. 3C and 3D). At 3 h,
HU treatment not only increased 4-HNE-protein adducts with
GAPDH but also decreased the amount of GAPDH detected
and altered the protein conformation of GAPDH, as reﬂected
by a shortened protein migration tail toward the lower
isoelectric point.
Effects of HU Exposure on GAPDH Enzymatic Activity and
Lactate Production
To determine if the formation of GAPDH-4-HNE adducts
affected the catalytic activity of GAPDH, we measured its
enzymatic activity in the embryo 3 h after exposure of the dams
to vehicle or HU. Although GAPDH immunoreactivity in the
head, body, and tail were not signiﬁcantly affected (Supplemen-
tary ﬁg. 1), GAPDH activity was signiﬁcantly decreased in the
HU400-treated group (20%), but not the HU600 group,
compared with saline (Fig. 4A). The appearance of lactate was
measured in whole embryos exposed to HU as a measure of the
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dominantly in anaerobic glycolysis and is an important source
of ATP production in the embryo. A 20% decrease in lactate
production was observed in embryos exposed to HU400,
whereas a 40% decrease occurred in embryos exposed to
HU600 (Fig. 4B).
HU Promotes the Nuclear Translocation of GAPDH
In cell cultures, oxidative stress has been reported to induce
the nuclear translocation of GAPDH (Nakajima et al., 2007;
Oritz-Oritz et al., 2010); thus, we focused on image analysis to
localize GAPDH. Initially, confocal microscopy presented
discreet homogeneous spots of immunoreactive GAPDH in
both vehicle- and HU-treated embryos, and it was challenging
to accurately measure nuclear versus cytoplasmic localization
in both treatment groups (Fig. 5). Consequently, we quantiﬁed
the subcellular localization of GAPDH with z-stack imaging
coupled with IMARIS, an advanced 3D imaging software. The
lumbosacral somites, the caudal area with the most signiﬁcant
malformations, were the focus of this analysis. A 3D surface
render of GAPDH revealed the subcellular localization of
GAPDH. In both vehicle- and HU-treated groups, GAPDH
immunoreactivity was unevenly distributed within the 3D
projection of a given cell; although GAPDH was present both
in the cytoplasm and nucleus, its density increased toward the
nuclear membrane (Figs. 6A and 6B). A masking technique in
IMARIS was applied that subtracted the cytoplasmic from the
nuclear staining using DAPI as the nuclear border to quantify
nuclear GAPDH (Fig. 6D). Interestingly, although GAPDH
was present within the nucleus of nontreated groups, in
agreement with the literature, a twofold increase in the nuclear
localization of GAPDH was observed in embryos exposed to
HU600 compared with saline-treated embryos (Fig. 7).
DISCUSSION
The reactive hydroxylamine group of HU induces ROS,
promoting the formation of reactive aldehydes such as 4-HNE
through lipid peroxidation (Grimsrud et al., 2008; LoPachin
et al., 2009). In previous studies, we reported that 4-HNE-
protein adduct immunoreactivity was enhanced in the caudal,
malformation-sensitive tissues of embryos exposed to HU. In
this study, we identify protein targets of 4-HNE in the tail
region of teratogen-exposed embryos. Covalent modiﬁcations
of 4-HNE to proteins involved in energy metabolism, including
GAPDH, were detected.
FIG. 2. 2D gel electrophoresis of the tail samples obtained from embryos treated with saline (controls, A) or HU (600 mg/kg, B) and the corresponding 2D
Western blots illustrating immunoreactive 4-HNE-protein adducts (C, control; D, HU 600 mg/kg treated). Spots 1–8 were analyzed by MS (see Table 1); (n ¼ 2).
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the developing embryo, is susceptible to 4-HNE-protein adduct
formation. Furthermore, glycolytic metabolism is reduced in
treated embryos. During midorganogenesis (GD 8.5–9.5), the
embryo undergoes a metabolic switch from anaerobic to aerobic
respiration, coincident with mitochondrial maturation, vascular
development, and chorioallantoic coupling (Alcolea et al.,2 0 0 7 ;
Shepard et al.,1 9 9 8 ). At this stage, oxidative phosphorylation
has yet to become an important source of energy; indeed,
inhibition of the electron transport chain with carbon monoxide
on GD 9 does not produce an adverse reaction (Robkin, 1997).
Prior to this switch, lactate is the major molecule used in the
synthesis of ATP; once this switch has taken place, the reaction
equilibrium to pyruvate for transfer into the mitochondria
becomes dominant and decreases lactate production. Lactate
levels measured in the embryo in this study reﬂect those of
anaerobic glycolysis at GD 9 (4.3 ± 0.8 mmol/l); this is expected
to drop (to 2.9 ± 0.3 mmol/l) once the embryo reaches GD 10
TABLE 1
The Identiﬁcation of Proteins Conjugated with 4-HNE in the Tail Regions of Embryos
Spot no. Protein name Function MW pI Sequence coverage (%)
#1 Unnamed protein — 50.4 9.1 24
#2 GOT2 Amino acid metabolism, Kreb’s cycle 47.8 9.13 28
#3 ALDOA Glycolysis 39.8 8.31 49
#4 SCYE1 Protein translation, apoptosis 35.5 8.75 40
#5 GAPDH Glycolysis 36.1 8.44 44
#6 HNRNP A1A RNA processing 34.3 9.27 23
#7 Albumin Transport protein in serum 70.7 5.75 41
#8 Chaperonin subunit theta Chaperone 60.1 5.44 47
HSPD1 (possible) Chaperone 61.1 5.91 10
Note. MW, molecular weight; pI, isoelectric point.
FIG. 3. 2D gel electrophoresis of the tail samples obtained from embryos treated with saline (control, A) or HU (600 mg/kg, HU600) (B) and the
corresponding 2D Western blots illustrating GAPDH immunoreactive protein spots (control, C; HU600, D); (n ¼ 2).
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only 2 mol of ATP/unit time as compared with aerobic
glycolysis, which produces ATP 183 faster. This difference in
rate outlines the limitation of anaerobic glycolysis, 2 versus
38 mol of ATP for oxidative phosphorylation. The decrease in
glycolytic activity of GAPDH and the subsequent decrease in
lactate at this critically susceptible respiratory period suggest that
ATP may be deﬁcient during this crucial stage of development.
It has been suggested that the reduction of ATP below a critical
threshold causes teratogenesis (Ritter et al.,1 9 7 5 ).
Another glycolytic target of 4-HNE-protein adducts that has
been identiﬁed within the caudal region of the embryo is
fructose-bisphosphate ALDOA1. There are three ALDO
isozymes (A, B, and C); ALDOA1 is mainly produced by
the developing embryo and is responsible for the conversion of
fructose 1,6-diphosphate into dihydroxyacetone phosphate and
glyceraldehyde-3-phosphate in the glycolytic pathway. 4-HNE-
protein targets in Parkinson’s disease were identiﬁed to be
ALDOA1 and GAPDH contributing to the metabolic dysfunc-
tion of the frontal lobe in the brain (Go ´mez and Ferrer, 2009);
however, there is limited literature reporting that 4-HNE forms
protein adducts with ALDOA1. This is the ﬁrst identiﬁcation of
GAPDH-4-HNE and ALDOA1-4-HNE-protein adducts within
the caudal, malformation-sensitive tissue of the developing
embryo. Other glycolytic enzymes in muscle, such as enolase,
which are a target of 4-HNE-protein adducts, have been shown
to have altered enzymatic activity, akin to the enzymatic
activity of GAPDH (Hussain et al., 2006). We propose that
FIG. 5. Confocal microscopy images of saline (control, A) or HU (600 mg/kg, HU600, B)-treated embryos. Green ﬂuorescence represents GAPDH
immunoreactivity; (n ¼ 5).
FIG. 4. (A) Spectrophotometric analysis of NADH as a measure of GAPDH activity in whole embryo samples after treatment with saline (control), low-dose
HU (400 mg/kg, HU400), or high-dose HU (600 mg/kg, HU600); (n ¼ 7). (B) Lactate measurements of whole embryo samples treated with saline (control),
low-dose HU (400 mg/kg, HU400), or high-dose HU (600 mg/kg, HU600); (n ¼ 3). Asterisk denotes a signiﬁcant difference between control and treated group
(*p < 0.05).
692 SCHLISSER, YAN, AND HALESHU-induced caudal malformations may in part be caused by
the aberrant regulation of energy metabolism resulting in cell
arrest and death.
In response to the decrease in metabolic function of GAPDH,
its nuclear translocation is enhanced. Nuclear translocation of
GAPDH is hypothesized to be a stress response during exposure
to free radicals and to play a role in the initiation of apoptosis in
damaged cells. 2D gel electrophoresis reveals that 4-HNE
modiﬁes GAPDH. We hypothesize that GAPDH is primarily
modiﬁed in the cytoplasm where it comes in direct contact with
4-HNE. Once 4-HNE modiﬁes GAPDH, it is then translocated
into the nucleus, whereby it may form new complexes with
nuclear proteins, such as p300/CBP and p53, to initiate a cell
death signaling cascade. Modiﬁcations of GAPDH in the
cytoplasm in response to oxidative stress are assumed to be
the primary event leading to nuclear localization. 4-HNE–
conjugated GAPDH has altered electrophoretic mobility, in-
dicating a conformational change. Accumulating evidence
suggests that modiﬁcations to GADPH render it an apoptosis
executor during oxidative stress (Chuang et al.,2 0 0 5 ).
In RAW264.7 cell lines, a murine macrophage-like cell line,
GAPDH is S-nitrosylated on cysteine 150, abolishing its
enzymatic activity (Sen et al., 2008). Upon S-nitrosylation,
GAPDH interacts with Siah1, a protein containing a nuclear
localization signal that permits the nuclear translocation of
GAPDH because it lacks this sequence. GAPDH becomes
acetylated by p300/CBP and mediates apoptosis. The hydrox-
ylamine group of HU has been reported to produce nitric oxide
in vivo (Lou et al., 2009); however, whether GAPDH is
S-nitrosylated in the fetal embryo at GD 9 and its possible role
in mediating the nuclear translocation of GAPDH has yet to be
elucidated. In addition to 4-HNE and S-nitrosylation modiﬁ-
cations of GAPDH, poly(adenosine diphosphate-ribose) (ADP-
ribose) polymerase (PARP) plays an important role in the
embryo upon stress. PARP becomes cleaved and activated in
FIG. 7. Intensity mean analysis of nuclear GAPDH, provided by IMARIS
software, of embryos treated with saline (control) or HU (600 mg/kg, HU600).
Asterisk denotes a signiﬁcant difference between control and treated group
(*p < 0.05).
FIG. 6. IMARIS 3D-rendered surface of lumbosacral somites (control sample) to show technique. (top left) Raw data, blue: DAPI, green: GAPDH; (top right)
3D-rendered surface of GAPDH and DAPI combined; (bottom left) 3D-rendered surface of DAPI; (bottom right) 3D surface of DAPI removed leaving nuclear
GAPDH; (control n ¼ 6, HU600 n ¼ 7).
OXIDATIVE STRESS TARGETS GAPDH IN EMBRYOS 693response to DNA damage and/or oxidative stress, modifying
many speciﬁc substrates (Koh et al., 2005). Activated PARP
cleaves oxidized nicotinamide adenine dinucleotide (NAD
þ)t o
nicotinamide and ADP-ribose and polymerizes the latter on
cytoplasmic proteins, nuclear acceptor proteins such as
histones, transcription factors, and PARP itself. Poly(ADP-
ribosyl)ation contributes to DNA repair and to the maintenance
of genomic stability (Wang et al., 1997). However, activation
of PARP also depletes cellular NAD
þ, which subsequently
triggers ATP depletion (Ha and Snyder, 1999). Moreover,
there is evidence that GAPDH is modiﬁed by poly(ADP-
ribosyl)ation, causing it to become enzymatically inactivated
and leading to further depletion of ATP.
The decrease in energy production in the embryo as a result
of the attenuation of glycolysis and the nuclear translocation of
GAPDH suggest that GAPDH may serve as an intracellular
sensor of oxidation and may play an early and pivotal role in
the cascade leading to apoptosis. The translocation of GAPDH
from the cytoplasm to the nucleus appears to be a critical step
in the induction of apoptosis (Dastoor and Dreyer, 2001).
Further insight into protein modiﬁcations in region-speciﬁc
areas of the embryo may better our understanding of its role in
oxidative stress–mediated teratogenicity.
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